BioInvent International AB (publ) (BOVNF) Financials
BOVNF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 55.9 million | 10.0 million |
| Dec. 31, 2025 | 72.7 million | 12.3 million |
| Sept. 30, 2025 | 82.9 million | 10.8 million |
| June 30, 2025 | 97.0 million | 11.2 million |
BOVNF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -13.9 million | 71662 |
| Dec. 31, 2025 | -9.9 million | 45723 |
| Sept. 30, 2025 | -11.1 million | ? |
| June 30, 2025 | 6.9 million | 236631 |
BOVNF Net Income
No data available :(
BOVNF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 47.7 million | - | 653420 |
| Dec. 31, 2025 | 64.2 million | 125343 | 125343 |
| Sept. 30, 2025 | 72.8 million | - | 167960 |
| June 30, 2025 | 84.4 million | - | 1.4 million |
BOVNF Shares Outstanding
BOVNF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 65916 | 12.3 million | 1.8 million | - |
| Dec. 31, 2025 | 138559 | 12.2 million | 1.7 million | - |
| Sept. 30, 2025 | 212339 | 12.6 million | 1.4 million | - |
| June 30, 2025 | 145871 | 15.3 million | 1.9 million | - |
BOVNF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 1.4 million | - |
| Dec. 31, 2025 | 326738 | - |
| Sept. 30, 2025 | 350147 | - |
| June 30, 2025 | 21.0 million | - |
BOVNF
Price: $3.29
52 week price:
Earnings Per Share: -0.47 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 216.4 million